Ultrasonography

Ultrasound can differentiate spondyloarthritis-related enthesitis from other entheseal pathologies such as mechanical enthesitis, according to data published in Annals of the Rheumatic Diseases.

The risk for heart attack, stroke or all-cause death rose fourfold among patients with carotid atheromas containing microplastics or nanoplastics, compared with patients without plastics in their arteries, according to a recent study.

Lantheus Holdings announced the FDA has approved the supplemental new drug application for its perflutren lipid microsphere injection to improve ultrasound imaging in pediatric patients with suboptimal echocardiograms.

Using lung ultrasonography to identify acute chest syndrome in patients with sickle cell disease resulted in favorable diagnostic accuracy, sensitivity and specificity, according to results published in CHEST.

The FDA has granted 510(k) clearance to EndoSound for its Vision System, a novel endoscopic ultrasound device that attaches to upper gastrointestinal endoscopes, according to a company release.

In the ICU, point-of-care ultrasonography is recognized as a key device/tool for diagnosing various diseases and conditions, especially those in the field of pulmonology.

Pre-participation screening for risk factors for sudden cardiac death with focused cardiac ultrasound was shown to improve diagnosis in athletes while remaining cost-effective, researchers reported.

Referral to diagnostic imaging decreased with use of an ultrasound protocol in patients with suspected pulmonary embolism, according to a presentation at the European Respiratory Society International Congress.

With its noninvasive and portable nature, point-of-care ultrasonography is an emerging technological tool for critical care clinicians when diagnosing and caring for patients.

UltraSight announced it received FDA 510(k) clearance for its AI-guided ultrasound technology designed to assist providers without sonography experience acquiring point-of-care cardiac ultrasound images.